No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Truking Technology Limited, established in 2000 and headquartered in Changsha, China, specializes in the research, development, and innovation of machinery for the pharmaceutical and medical industries. The company delivers end-to-end manufacturing solutions for diverse sterile products, encompassing lyophilization, injectable ampoules and vials (for both liquid and powder forms), pre-filling and sealing operations, plastic bottle blow-fill-seal technology, cartridges, non-PVC soft bags, and glass infusion bottles. Its offerings also include specialized fluid processing systems, advanced isolating systems, and dedicated lyophilization laboratories. Operating with a significant international footprint, Truking Technology distributes its products to approximately 40 countries and regions across Asia, Europe, South America, and other global markets.
www.truking.cnNo one on the platform currently holds 300358.SZ.
No tracked institution reports a position in 300358.SZ as of their last filing.
No one on the platform has traded 300358.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 4.8% | — | — | — | ||
| Rev. Growth % | -1.1% | 10.0% | ||||
| Profit Margin % | 4.4% | 4.2% | 5.6% | |||
| Free Cash Flow Margin % | 8.5% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.6B | +6.3% | $0.16 | $0.16–$0.16 | — | 1 |
| 2027 | $6.3B | +13.3% | $0.28 | $0.28–$0.28 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300358.SZTruking Technology Limited | $8.09 | +0.50% | $5.8B | — |
| 002382.SZBlue Sail Medical Co.,Ltd. | $5.81 | +0.17% | $5.9B | — |
| 002950.SZAllmed Medical Products Co.,Ltd | $8.44 | -0.00% | $5.3B | — |
| 300158.SZShanxi Zhendong Pharmaceutical Co.,Ltd | $5.01 | -0.20% | $5.0B | — |
| 300267.SZHunan Er-Kang Pharmaceutical Co., Ltd | $3.17 | +2.26% | $6.5B | — |
| 300451.SZB-SOFT Co.,Ltd. | $3.34 | +0.60% | $5.2B | — |
| 300463.SZMaccura Biotechnology Co.Ltd | $8.95 | -0.11% | $5.4B | — |
Source: Financial Modeling Prep · peers by sector/industry